SCHEMBL2654520

SCHEMBL2654520

COC(=O)c1ccc(CC(C)COc2cc(C)c(Br)c(C)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
GAA P10253 2/20 0.42
TSHR P16473 1/20 0.42
MAPT P10636 6/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CCR6 P51684 1/20 0.40
HKDC1 Q2TB90 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
STAT3 P40763 1/20 0.39
NOD2 Q9HC29 1/20 0.39
PPARG P37231 1/20 0.39
TDP1 Q9NUW8 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655622 0.88 ALDH1A1 (0.45) LMNAALDH1A1HPGDGAATSHR
SCHEMBL2655045 0.74 CCR6 (0.44) LMNAALDH1A1HPGDGAAMAPT
SCHEMBL2653884 0.72 LOXL2 (0.56) ALDH1A1HPGDGAATSHRMAPT
SCHEMBL13543623 0.72 LOXL2 (0.56) ALDH1A1HPGDGAATSHRMAPT
SCHEMBL2654694 0.72 CYP4A11 (0.47) LMNAALDH1A1HPGDGAATSHR
SCHEMBL2653571 0.72 ADRB2 (0.41) LMNAALDH1A1HPGDMAPTRAB9A
SCHEMBL28295886 0.71 LOXL2 (0.54) ALDH1A1HPGDGAATSHRMAPT
SCHEMBL1765416 0.71 MEN1 (0.43) LMNAALDH1A1HPGDGAAMAPT
SCHEMBL15262354 0.71 ALDH1A1 (0.51) LMNAALDH1A1HPGDTSHRMAPT
SCHEMBL15600034 0.71 ALDH1A1 (0.47) LMNAALDH1A1HPGDTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957068-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-20 EP disclosed
WO-2007120270-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-25 WO disclosed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed